[Abstract] Leishmania is a genus of trypanosomatid protozoa and is the parasite responsible for the disease leishmaniasis. These protozoa, regulate their gene expression in an atypical way, compared to other higher eukaryotes. The regulation of gene expression is characterized by a predominance of post-transcriptional over pre-transcriptional regulatory mechanisms (Clayton, 2002) . Thus proteomic analysis has proven an essential tool for understanding pathways implicated in Leishmania infectivity, host-parasite interactions, drug resistance and others. When employing a comparative proteomics analysis between different parasitic cell lines, it is essential that these lines are cultivated in exactly the same way, in the same cell density and growth phase. More importantly when cell-cycle defects are suspected, it is essential to synchronize cell-lines in the same cell-cycle phase so as to eliminate possible artifacts. This protocol describes the preparation of whole-protein samples for proteomic analysis in Leishmania donovani (L. donovani).
Phosphate Buffered Saline (PBS)
5. The parasitic pellet is resuspended in 50 μl Lysis buffer using a pipette.
6. The lysed parasites are subjected to five freeze-thaw cycles in solid CO2/ethanol.
7. The sample is centrifuged at 20,000 x g for 30 min at 4 °C. 9. The sample is incubated for 30 min at RT under gentle rotation.
10. After the end of the incubation, the sample is centrifuged at 17,000 x g for 40 min at RT.
11. The supernatant can now be used for proteomic analysis or can be stored at -80 °C for future use.
Notes
1. Extra caution is required at all steps of the procedure as not the protein sample to be contaminated by environmental proteins (e.g. keratin). Preferably avoid using bare hands during the procedure.
2. After the addition of Rehydration buffer the sample should not be exposed to temperatures below 10 °C, due to urea-mediated sedimentation.
3. Bio-Lyte ® should be added just before the use of the Rehydration Buffer.
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